HT
Halozyme Therapeutics Inc
🇩🇪XSTU.RV7GermanyHealthcare
€93.72EURup +1.58 (+1.71%)ClosedEnd of day3:09 AM
Price€93.72+1.58 (+1.71%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US40637H1095
- CUSIP
- Not reported
Company
- Employees
- 423
- Headquarters
- San Diego, United States
- Website
- https://halozyme.com
- CEO
- Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- $3.41
- P/E LTM
- 22.66
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.66B+41.15%up year on year
- Net income
- $413.6M-25.78%down year on year
- Gross margin
- 78.18%-3.7%down year on year
- Free cash flow
- $806.22M+49.11%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.